Case number 1:20-cv-01334
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 19, 2022 | N/A | Terminated Case (0) Docket Text: CASES CLOSED per the CONSENT JUDGMENT AND PERMANENT INJUNCTION FILED IN CIV. NO. 18-651-CFC. Associated Cases: 1:19-cv-00926-CFC, 1:20-cv-00235-CFC, 1:20-cv-00318-CFC, 1:20-cv-01334-CFC, 1:21-cv-00283-CFC(nmf) |
| Feb 3, 2021 | 24 | Scheduling Order (22) Docket Text: SCHEDULING & CONSOLIDATION ORDER: 18-651-CFC SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN 18-651-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 8/20/2021. Joint Claim Construction Brief due by 7/23/2021. A Markman Hearing is set for 8/25/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 2/16/2022. A Final Pretrial Conference is set for 3/9/2022 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 3/28/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 2/3/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Feb 3, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00651-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-651-CFC ONLY. (nmf) |
| Feb 3, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(cak) |
| Jan 29, 2021 | 23 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.s Supplemental Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 29, 2021 | 22 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Vanda Pharmaceuticals Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (205 in 1:18-cv-00651-CFC, 21 in 1:20-cv-01334-CFC, 18 in 1:20-cv-01104-CFC, 20 in 1:20-cv-01333-CFC) Stipulation filed by Vanda Pharmaceuticals Inc.. Ordered by Judge Colm F. Connolly on 1/29/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) |
| Jan 27, 2021 | 21 | Stipulation (5) Docket Text: Joint STIPULATION and [Proposed] Order Regarding Amendment of Expert Report by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 27, 2021 | 20 | Proposed Order (22) Docket Text: Joint PROPOSED ORDER Joint [Proposed] Scheduling Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jan 25, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf of the stipulation to extend time has been replaced to reflect the correct year. The text of the stipulation as well as the "so ordered" entry have also been updated to change the year to 2021 in the text. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Jan 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (18 in 1:20-cv-01333-CFC, 19 in 1:20-cv-01334-CFC, 203 in 1:18-cv-00651-CFC, 16 in 1:20-cv-01104-CFC) STIPULATION TO EXTEND TIME for the parties to submit a Scheduling Order to January 27, 2021 filed by Vanda Pharmaceuticals Inc. Ordered by Judge Colm F. Connolly on 1/25/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) Modified on 1/25/2021 (nmf). |
| Jan 22, 2021 | 19 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a Scheduling Order to January 27, 2021 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 1/25/2021 (nmf). (Main Document 19 replaced on 1/25/2021) (nmf, ). |
| Jan 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:20-cv-01333-CFC, 202 in 1:18-cv-00651-CFC, 15 in 1:20-cv-01104-CFC, 18 in 1:20-cv-01334-CFC) Stipulation filed by Teva Pharmaceuticals USA, Inc.. Ordered by Judge Colm F. Connolly on 1/19/2021. Associated Cases: 1:18-cv-00651-CFC, 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(fms) |
| Jan 15, 2021 | 18 | Stipulation (3) Docket Text: STIPULATION (and proposed order) to extend time to submit proposed revised scheduling order by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Jan 8, 2021 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 1/8/2021. (Court Reporter V. Gunning.) Counsel to confer and submit a revised proposed scheduling order to the Court on or before January 15, 2021. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Jan 5, 2021 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Dec 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (14 in 1:20-cv-01333-CFC, 13 in 1:20-cv-01104-CFC, 16 in 1:20-cv-01334-CFC) Letter, Order Setting Telephonic Scheduling Conference:( A Scheduling Conference is set for 1/8/2021 at 01:00 PM before Judge Colm F. Connolly. Counsel for Plaintiff shall coordinate the call and email the dial-in information to chambers.) Ordered by Judge Colm F. Connolly on 12/22/2020. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Dec 21, 2020 | 16 | Text of Proposed Order [Proposed] Scheduling Order (20) |
| Dec 21, 2020 | 16 | Main Document (2) Docket Text: Letter to The Honorable Colm F. Connolly from Derek J. Fahnestock regarding joint proposed Scheduling Order. (Attachments: # (1) Text of Proposed Order [Proposed] Scheduling Order)(Fahnestock, Derek) |
| Nov 23, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin E. Warner for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 23, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper for MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Reid F. Smith and Elizabeth E. Grden filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., [13] MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner and Bryce A. Cooper filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/20/2020. (nmf) |
| Nov 19, 2020 | 15 | Certification of Reid F. Smith (1) |
| Nov 19, 2020 | 15 | Certification of Elizabeth E. Grden (1) |
| Nov 19, 2020 | 15 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Reid F. Smith and Elizabeth E. Grden - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Reid F. Smith, # (2) Certification of Elizabeth E. Grden)(Bilson, David) |
| Nov 19, 2020 | 14 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before December 21, 2020, counsel for plaintiff shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted or alternatively, submit a joint proposed scheduling order to the Court. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/21/2020.) Signed by Judge Colm F. Connolly on 11/19/2020. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Nov 19, 2020 | 13 | Certification of Bryce A. Cooper (1) |
| Nov 19, 2020 | 13 | Certification of Kevin E. Warner (1) |
| Nov 19, 2020 | 13 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner and Bryce A. Cooper - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Kevin E. Warner, # (2) Certification of Bryce A. Cooper)(Bilson, David) |
| Nov 16, 2020 | 12 | Answer to Counterclaim (12) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 26, 2020 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc.; Corporate Parent No parent corporations for MSN Laboratories Private Limited filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Phillips, John) |
| Oct 26, 2020 | 10 | Answer to Complaint (20) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Phillips, John) |
| Oct 22, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein, Jennifer Rea Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(kmd) |
| Oct 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (7 in 1:20-cv-01334-CFC, 10 in 1:20-cv-01104-CFC, 9 in 1:20-cv-01333-CFC) MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein and Jennifer Rae Deneault filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/13/2020. Associated Cases: 1:20-cv-01104-CFC, 1:20-cv-01333-CFC, 1:20-cv-01334-CFC(nmf) |
| Oct 8, 2020 | 9 | Return of Service Executed (2) Docket Text: Return of Service Executed by Vanda Pharmaceuticals Inc.. MSN Pharmaceuticals Inc. served on 10/8/2020, answer due 10/29/2020. (Fahnestock, Derek) |
| Oct 8, 2020 | 8 | Return of Service Executed (2) Docket Text: Return of Service Executed by Vanda Pharmaceuticals Inc.. MSN Laboratories Private Limited served on 10/8/2020, answer due 10/29/2020. (Fahnestock, Derek) |
| Oct 8, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (9) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Josephine Young, Daniel J. Klein and Jennifer Rae Deneault - filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Oct 7, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:20-cv-01333-CFC, 1:20-cv-01334-CFC (rjb) |
| Oct 1, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Oct 1, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by Vanda Pharmaceuticals Inc. (kmd) |
| Oct 1, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,610,510 ; 10,510,511. (kmd) |
| Oct 1, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: n/a. Date of Expiration of Patent: see attached. (kmd) |
| Oct 1, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Oct 1, 2020 | 1 | Civil Cover Sheet (2) |
| Oct 1, 2020 | 1 | Exhibit A-B (42) |
| Oct 1, 2020 | 1 | Main Document (16) Docket Text: COMPLAINT for Patent Infringement filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. (Filing fee $400, receipt number ADEDC-3237798.) - filed by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibits A-B, # (2) Civil Cover Sheet)(kmd) |
